DUBLIN, Calif., Sept. 6 SuperGen, Inc.(Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapiddevelopment and commercialization of therapies for solid tumors andhematological malignancies, today announced that James S. Manuso, Ph.D.,President and Chief Executive Officer, is scheduled to present at the BearStearns Annual Healthcare Conference on September 11, 2007, at The Grand Hyattin New York.
SuperGen's presentation at the Bear Stearns Annual Healthcare Conferenceis scheduled to begin at 4 p.m. EDT. A live webcast of the presentation willbe available on the investor relations section of the Company's Web site atwww.supergen.com. The webcast will be archived for 90 days.
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical companydedicated to the discovery, rapid development and commercialization oftherapies for solid tumors and hematological malignancies. SuperGen isdeveloping a number of therapeutic anticancer products focused on kinase andcell signaling inhibitors and DNA methyltransferase inhibitors. For moreinformation about SuperGen, please visit http://www.supergen.com.Contacts Timothy L. Enns Mary M. Vegh SuperGen, Inc. SuperGen, Inc. SVP, Corporate Communications & Manager, Investor Relations Business Development Tel: (925) 560-2845 Tel: (925) 560-0100 E-mail: [email protected]
E-mail: [email protected]
SOURCE SuperGen, Inc.